Comparative evaluation of small molecules reported to be inhibitors of biofilm formation.

Because biofilm formation is such a problematic feature of infections, much effort has been put into identifying biofilm inhibitors. However, the results observed with these compounds are often reported in isolation, and the methods used to assess biofilm formation vary between labs, making it impossible to assess relative efficacy and prioritize among these putative inhibitors for further study. The studies we report address this issue by directly comparing putative biofilm inhibitors using a consistent assay. This assay was previously shown to maximize biofilm formation, and the results observed with this assay have been proven to be relevant . Of the 19 compounds compared using this method, many had no impact on biofilm formation under these conditions. Indeed, only one proved effective at limiting biofilm formation without also inhibiting growth.